True or False: Prior to prescribing a controlled substance, a review of KASPER and relevant patient information is required.

True or False: Prior to prescribing a controlled substance, a review of KASPER and relevant patient information is required.

• A. True
• B. False
• C. Only for certain medications
• D. True, if the patient is a minor

Answer: (A)

The statement is true because Kentucky law mandates that healthcare practitioners must review the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) and relevant patient information before prescribing controlled substances. This requirement is in place to help combat prescription drug abuse and ensure safe prescribing practices. KASPER provides valuable information about a patient's prescription history, allowing prescribers to make informed decisions and assess the potential risks associated with prescribing controlled substances. This practice not only protects patients but also helps in identifying potentially dangerous patterns of medication use that could lead to misuse or abuse. The emphasis on a thorough review prior to prescribing aligns with ethical standards that prioritize patient safety and responsible prescribing. In contrast, the other options either undermine this requirement or misrepresent the scope of the law, as the review is not limited to specific medications or patient demographics, but is a universal requirement for all controlled substances.

The statement is true because Kentucky law mandates that healthcare practitioners must review the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) and relevant patient information before prescribing controlled substances. This requirement is in place to help combat prescription drug abuse and ensure safe prescribing practices.

KASPER provides valuable information about a patient's prescription history, allowing prescribers to make informed decisions and assess the potential risks associated with prescribing controlled substances. This practice not only protects patients but also helps in identifying potentially dangerous patterns of medication use that could lead to misuse or abuse. The emphasis on a thorough review prior to prescribing aligns with ethical standards that prioritize patient safety and responsible prescribing.

In contrast, the other options either undermine this requirement or misrepresent the scope of the law, as the review is not limited to specific medications or patient demographics, but is a universal requirement for all controlled substances.